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ABSTRACT 
Objective: Ectodermal dysplasia syndrome is a complex group of genetic disorders 
identified by the abnormal development of the ectodermal structures. The aim of this 
retrospective clinical case series report was to evaluate the outcomes of the 
ectodermal dysplasia syndrome patients that underwent zygomatic implant surgery. 
Materials and Methods: A total of 9 ectodermal dysplasia syndrome patients aged 
between 21 to 56 years (mean age 36.8) with severely atrophic maxilla were included 
in this study. All the patients were treated with a total of 19 zygomatic implants. The 
mean follow-up of the patients was 55 months (with a range of 44 to 84 months). The 
implant survival rate was evaluated as a primary outcome. The intra and postoperative 
complications were evaluated as additional criteria for success. 
Results: The overall implant survival rate was 100 % without any complications. 
Final or provisional prosthesis were delivered on the same day of surgery, which 
resulted in an improvement of the quality of life of the patients. 
Conclusion: According to the results of this study, zygomatic surgery can be 
considered as a viable and safe alternative to conventional treatment modalities for 
oral rehabilitation of ectodermal dysplasia syndrome patients.
Page 2 of 33Oral Diseases
3INTRODUCTION
Ectodermal dysplasia (ED) was first defined by Charles Darwin in 1860s (Balshi & 
Wolfinger, 2002). ED is a syndrome of a complex group of hereditary or congenital 
malformations identified by the abnormal development of the ectodermal structures 
(Itin & Fistarol, 2004, Lypka et al., 2008). The transmission of the ED can be either 
autosomal dominant or recessive. The characteristics of the condition include 
abnormal development of the skin, sweat glands, sebaceous glands, hair, nails, and 
teeth (Itin, 2013, Itin & Fistarol, 2004, Lypka et al., 2008). Additionally, ED 
syndrome can affect other organs, which develop from ectoderm such as, nervous 
system, tooth enamel, mammary glands. In general, ED can occur in isolation or in 
association with other more complex clinical manifestations involving the 
mesodermal and endodermal structures (Itin, 2013, Carvallo, et al., 2013). 
Dental dystrophies of the ED contain complete anodontia, hypodontia and oligodontia 
(Deshpande& Kumar, 2010). The clinical oral manifestations of ED patients include 
maxillary hypoplasia, mandibular protrusion, and developmental defects of the 
alveolar ridges (Bani et al., 2010, Wang et al., 2019).
Oral rehabilitation in ED patients represents a major surgical challenge (Deshpande et 
al., 2010). This difficulty is primarily due to anatomical problems, such as the shape 
and density of the edentulous jaw bones and secondly due to the poor quality of the 
oral soft tissue with limited attached gingiva. These factors are usually considered as 
unfavorable for the prognostic of healing in cases of bone grafts and dental implants.  
Ectodermal dysplasia has a negative impact on the oral health-related quality of life of 
patients (Hanisch et al., 2019). According to a systematic review by Wang et al in 
2016 dental implants with or without bone augmentation are commonly used methods 
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4for oral rehabilitation of ED syndrome (Wang et al., 2016, Deshpande & Kumar, 
2010). The insertion of conventional dental implants in patients with ectodermal 
dysplasia syndrome were reported in literature with high survival rates by several 
authors (Chrcanovic, 2018)
Zygomatic implants (ZI) were introduced by Branemark as a successful and 
promising alternative for oral rehabilitation of the patients with extremely atrophic 
maxillary bone (Malo 2008, Branemark 1998).  The advantages of the technique 
include reduced number of surgeries, reduced time, decreased need for additional 
bone grafting, and less expenses when compared to conventional implant procedures 
(Chana 2019, Aparicio 2006, Aparicio 2014). Dental rehabilitation of ED patients 
with zygomatic implant fixations and maxillary prosthesis were reported in literature, 
although with very limited numbers (Peñarrocha-Diago et al., 2004, Balshi et al., 
2002). Wang et al in a radiographic study evaluated the anatomical features of ED 
patients and reported that the development of zygomatic thickness and length in ED 
patients with oligodontia can be limited and can represent some difficulties for 
zygomatic implant insertions (Wang et al., 2019). 
The oral rehabilitation of ED patients is quite challenging with conventional implants 
and prosthesis in terms of function and esthetics. One of the major limitations is the 
severe maxillary hypoplasia and success might decrease critically due to insufficient 
retention and stability of the prosthesis. Integration of zygomatic implant surgery with 
implant-supported prosthetic rehabilitation can significantly optimize the quality of 
life of the ED patients. The aim of this retrospective clinical case series report was to 
evaluate the outcomes of ectodermal dysplasia syndrome patients that underwent oral 
rehabilitation with zygomatic implant surgery. 
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This retrospective study consisted of 9 ectodermal dysplasia syndrome patients with 
severely atrophic maxilla that were treated with zygomatic implants at the Department 
of Dentistry and Maxillofacial Surgery, University of Milan, (section of Galeazzi 
Hospital, Italy) between March 2013 and March 2016 (out of 76 ED patients that 
received oral rehabilition in the same section). A signed informed consent agreement 
form was obtained from all the patients and the study protocol was in compliance 
with the principles laid down in the Declaration of Helsinki on medical protocol. This 
study was approved by institutional scientific review board of Galeazzi Hospital 
(Milan, Italy; authorization no. 2552377-L2058. "Implant rehabilitation of the 
partially or totally edentulous patient: evaluation of techniques and materials to 
improve predictability and maintenance”). The data of the patients were identified 
from the medical records as ectodermal dysplasia syndrome patients with severely 
atrophic maxilla that were treated with the use of implants inserted into the zygomatic 
bone. 
Inclusion criterion was ectodermal dysplasia syndrome patients with severely atrophic 
maxilla and failure of previous bone grafting procedures that were treated with 
zygomatic implants. No additional exclusion criterion was set. The surgical, 
prosthetic and the follow-up protocol were described in detail in a previous article by 
the same team (Goker et al. 2020).
Presurgical protocol included clinical examinations with preoperative cone beam 
computed tomography (CBCT) scans and panoramic radiographs. A professional oral 
hygiene session was given to each patient one week before the surgical operations. 
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6All the patients were prescribed with pre- and post-operative antibiotics (Augmentin 
at a dosage of 1-g tablet every 8 hours for a total of 6 days or Azithromycin 500 mg 
for 3 days in cases of allergy to penicillin).
All surgeries were carried out by the same surgeon (Fr.G.) under general and with 
local anesthesia (4% articaine with 1:100,000 adrenalin). “Extra- sinus approach” was 
utilized in all patients for insertion of zygomatic implants (Noris Medical Ltd., Israel 
or Medentis Medical ICX GmbH, Germany). In brief; the operation started with a 
palatal incision in the maxillary crest with vertical posterior releasing incisions and 
the muco-periosteal flap reflections. After flap reflection, all the bone surgeries and 
the implant site preparations were performed using drills and burs according to the 
instructions from the manufacturer. Finally, the ZIs were carefully inserted at a low 
speed (max 40 rpm), with a torque of 40 to 80 Ncm. The last 360 turn is done 
manually with an extraoral screwdriver. The surgical sites were covered with 
resorbable membrane or with Bichat fat pad and the wounds were repositioned and 
sutured using continuous resorbable sutures (Vicryl, Ethicon FS-2, Johnson & 
Johnson, USA). 
Final or provisional prosthesis were delivered on the same day of surgery, which 
resulted in an improvement of the quality of life of the patients. The patients were 
recalled for clinical follow-up after 10 days, 1 month and every 3 months for the first 
year, and then twice a year. The occlusion was examined carefully at the delivery of 
the final prostheses and at each follow-up. In the first year following ZI insertions, 
follow up criteria for the patients with Toronto bridge prosthesis included additional 
interventions. Every six months, Toronto bridge prosthesis were unscrewed to check 
the status of the surrounding tissues. 
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complications were evaluated as additional criteria for survival. Implant survival rate 
was evaluatedaccording to the following clinical and radiological criteria:
 absence of clinically detectable implant mobility;
 no evidence of peri-implant radiolucency;
 no spontaneous ZI failure;
 absence of pain, and infections.
The representative pre-operative intraoral and panoramic x-ray views of one of the 
ED patients can be seen in Figure 1 and Figure 2. The representative intraoral and 
panoramic x-ray views of the same patient with zygomatic implants inserted can be 
seen in Figure 3 and Figure 4. Figure 5 and Figure 6 are intraoral views at 18 months 
follow up. Figure 7 shows the panoramic x-ray image from 26 months after insertion 
of implants, which was taken at the last follow up appointment.
This article was written following the STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) guidelines (http://www.strobe -statement.org, 
von Elm, et al., 2008).
Statistical analysis
Given the small sample size, descriptive statistics was done using mean values and 
range for quantitative variables. The effect of the different variables (gender, age, 
antagonist dentition, reason for ZI, Number of zygomatic and conventional implants, 
loading mode, prosthesis type, and ZI location) on implant survival was not evaluated, 
because no failures occurred in this study. Statistical analysis was performed using 
GraphPad Prism 5.03 (GraphPad Software, Inc., La Jolla, CA, USA).
RESULTS 
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8A total of 9 ectodermal dysplasia syndrome patients aged between 21 to 56 years 
(mean age 36.8) with severely atrophic maxilla were included in this study. In the 
population, one of the patients had diabetes and no other patient had any additional 
chronic or other health condition. 
All the included patients were Class VI -V Cawood and Howell. The quality of bone 
of all patients was D1 and D2, which can be assumed to be mainly due to the total 
absence of the teeth.  
Eight patients had severe oligodontia (with six or more teeth missing: 
1- Maxilla (2 incisors+2 canine+2 molar) Mandible(none)
2- Maxilla (none) Mandible (4 incisors+2 canine+4 premolar+1 molar)
3- Maxilla (3 incisors) Mandible (none)
4-Maxilla (3 incisors) Mandible (none)
5- Maxilla (4 incisors+2 canine) Mandible (none)
6-Maxilla (3 incisors) Mandible (none)
7-no teeth in maxilla and mandible 
8-Maxilla (4 incisors) Mandible (2 canine+2 molar)
9-Maxilla (4 incisors+1 premolar) Mandible (2 molar)
All the patients had severely atrophic maxilla (6 patients with atrophic maxilla, 3 
patients with atrophic maxilla and failures of previous bone grafting procedures (2)/ 
implants (1). Three of the patients had additional orthognathic surgery (Le Fort 1 
osteotomy) and only one patient had orthodontic treatment with braces before 
zygomatic implant surgery. All the other patients had oral rehabilitation with 
zygomatic implant surgical management without any additional treatment modalities.  
Two of the patients had failures from previous grafts. One of these was failures was 
due to a dehiscence in iliac flap. One patient had a failure of previous conventional 
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implants was considered.
 All the patients were treated with a total of 19 zygomatic implants. The mean follow-
up of the patients was 55 months (with a range of 44 to 84 months). 
Primary stability was achieved in all implants with minimum insertion torque of 40 
Ncm. Five of the patients received immediate loading of the prothesis while four of 
the prothesis were done in a delayed approach. The decision for loading protocol 
based on the request of each patient mostly due to economic reasons, independent of 
the primary stability of the ZI. 
The overall implant survival rate in this study was 100% without any complications 
and without any dropouts.  Eight of the patients had acrylic resin Toronto bridge 
prosthesis and one patient had metal-acrylic resin prostheses. Details on antagonist 
dentition can be listed as follows; one patient with acrylic resin Toronto bridge 
prosthesis, one patient with fixed metal-acrylic resin prosthesis on natural teeth, one 
patient with removable prosthesis, two patients with natural teeth, three patients with 
implants with fixed metal-acrylic resin prosthesis, and one patient with natural teeth 
plus implants with fixed metal-acrylic resin prosthesis. 
Additional data of the study group concerning age, gender of the patients, number of 
zygomatic and conventional implants, ZI location are listed in Table 1. Type of 
prosthesis, loading protocol and antagonist dentition are listed in Table 2. 
DISCUSSION
The reconstruction of oral function in ectodermal dysplasia syndrome patients is a 
challenging situation for the oral and maxillofacial surgeon (Deshpande & Kumar 
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2010b). Oral rehabilitation of ED patients with dental implants is a common treatment 
modality, as reported by various authors (Wang et al., 2016, Lypka et al., 2008, 
Chrcanovic, 2018).  However, ED patients usually have reduced residual alveolar 
bone with “knife- edge” morphology, making implant reconstruction a challenge 
(Deshpande & Kumar 2010b). ED patients usually need additional interventions 
including bone grafting and/or sinus augmentation procedures (Worsaac et al., 2007, 
Guckes et al., 1991). Additionally, limitations in soft tissues can compromise the 
aesthetic results and can present a higher risk for possible biologic complications 
(Salinas et al., 2005).
Oral rehabilitation can afford ED patients,  the opportunity to have normal phonation, 
mastication, swallowing, and aesthetics in means of facial support (Grecchi et al., 
2010 a,b). The typical old-age appearance of the face can be  decreased by increasing 
the vertical dimension of the lower face.  Consequently, the temporomandibular joint 
functions can be improved (Grecchi et al., 2010 a,b). 
In ED patients sufficient bone may be available only at the mid- symphysial area in 
the mandible, where one implant could provide stability for a mandibular denture 
(Kearns et al., 1999). The maxilla is relatively more retruded than the mandible. 
Additionally, the nasal alar width and mouth width are usually significantly smaller 
than normal patients (Sforza et al., 2003, Dellavia et al., 2010). Total or partial 
removable prosthesis or overdentures is often the first treatment choice in most cases 
(Garagiola et al., 2007). However, prosthetic solutions using dental implants should 
be considered (Grecchi et al., 2010 a,b,  Kearns et al., 1999). Dental implants 
with/without bone grafts can be valuable devices with no difference compared with 
unaffected patients (Grecchi et al., 2010a). 
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Zygomatic implant (ZI) surgery can be considered as a treatment option for ED 
syndrome patients and was tested by researchers with positive results (Peñarrocha-
Diago et al., 2004, Balshi et al., 2002). However, data concerning the outcome of this 
approach in such patients is currently very limited. According to the successful results 
obtained from this study, the oral rehabilitation of ED patients can be a valuable 
treatment option. 
ZI is considered as a successful alternative for rehabilitation of patients with severe 
maxillary atrophy, however ZI insertion is a major surgery and can represent some 
risks (Aparicio et al., 2014, D’Agostino et al., 2016, Yates et al., 2014, Candel-Marti 
et al., 2012, Chrcanovic et al., 2016, Chrcanovic & Abreu, 2013, Brånemark et al., 
2004, Goker et al., 2020). The possible complications of ZI surgery include sinusitis, 
soft tissue infections, paresthesia, and oroantral fistula, penetration of the orbital 
cavity during the drilling protocol, and failure of the implants (Malo et al., 2015, 
Filho et al., 2016, Nobre, et al., 2014).
According to an anatomical analysis of zygomatic bone by Wang et al in 2019, 
zygomatic thickness and length in EC patients is usually limited and insufficient. This 
can represent some limitations, especially for quad (4 ZIs) zygomatic implantations 
(Wang et al., 2019) . However, where the anatomy is appropriate, the quad zygomatic 
protocols can be used. In the present study, the insertion of quad (four) ZIs was 
possible just in one patient.  Seven patients received bilateral 2 zygomatic implants 
(in the molar region), while one patient received unilateral 1 ZI. 
The incidence of EDs is approximately 7 in 10,000 (Bani et al., 2010) physiological 
and esthetic considerations in such patients are compromised due to the condition 
(Carvalho et al., 2013). The clinical manifestations of ED cause considerable social 
Page 11 of 33 Oral Diseases
12
problems in individuals affected by the condition (Carvalho et al., 2013). Patients 
with ectodermal dysplasia rate their quality of life worse than is usually prevalent in 
the normal population (Hanisch et al., 2019). Currently, long-term data outcome 
reports based on clinical evidence for conventional implant and bone augmentation 
procedures and or zygomatic implant interventions in ED patients are very limited.  
In the present study, the decision for loading protocol for prosthetic over-structure 
was discussed by each patient. The primary stability of the ZI was present in all the 
cases and the choice mostly was based on economic reasons. 
CONCLUSIONS
This retrospective clinical case series evaluated the outcomes of the ectodermal 
dysplasia syndrome patients that underwent zygomatic implant surgery with at least 3 
years follow up.  Limited outcomes per se were reported.   High success rate reported 
is mostly dependent on the experience of the single surgeon that performed all ZI 
surgeries. The limitations of the present study include a single center retrospective 
report with no control groups.  Future studies should focus on case-control studies 
with longer follow up periods and larger groups.
According to the results of this study, zygomatic surgery can be considered as a viable 
and safe alternative to conventional treatment modalities for oral rehabilitation of 
ectodermal dysplasia syndrome patients. However, clinicians must be aware that 
zygomatic implant insertion is a challenging procedure and is not risk free. Highly 
experienced surgeon with prior special training is crucial for safe procedures and 
successful outcomes. 
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FIGURE LEGENDS 
FIGURE 1: The initial intraoral image of an ectodermal dysplasia patient.
FIGURE 2: The initial panoramic x-ray image of the patient.
FIGURE 3: The post-prosthetic intraoral image of the patient.
FIGURE 4: The panoramic x-ray image of the same ectodermal dysplasia patient 18 
months after implant insertion surgery. Note: The conventional implants in the lower 
jaw of this patient were inserted using the technique of bypass of the inferior alveolar 
nerve. In this case, the position of the nerve was superficial, situated rather buccally in 
the mandibular bone and insertion of the implant was possible without damaging the 
nerve.
FIGURE 5: The intra-oral view of the patient 18 months after implant surgery. Front 
view.
FIGURE 6: The intra-oral view of the patient 18 months after implant surgery. 
Occlusal view.
FIGURE 7: The panoramic x-ray image of the patient 26 months after implant 
surgery.
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Table 1: Patient demographics and data regarding the implant success
Patient Age Gender N. ZI
N. 
CI
ZI 
location
Total 
follow 
up
ZI 
Survival 
%
Complications
1 51 F 2 4 16, 26 52 100 None
2 47 F 2 4 16, 26 60 100 None
3 21 F 2 4 16, 26 55 100 None
4 56 F 2 4 16, 26 46 100 None
5 25 M 2 2 16, 26 65 100 None
6 52 M 4 2 16, 26, 
13,23
44 100 None
7 27 M 2 2 16, 26 84 100 None
8 23 M 2 3 16, 26 77 100 None
9 29 F 1 4 26 51 100 None
ZI: Zygomatic implant, CI: Conventional implants, N: Number
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Table 2: Data regarding the prosthetic treatment 
Patient Loading
Prosthetis 
type
Antagonist 
dentition
Prosthesis 
Survival %
Complications
1 Immediate
toronto 
(resin)
Implant supported 
fixed prosthesis
100 None
2 Immediate
toronto 
(resin)
Natural teeth 100 None
3 Immediate
toronto 
(resin)
Natural teeth 100 None
4 Immediate
fixed 
(resin)
Implant-supported 
fixed prosthesis
100 None
5 Delayed
toronto 
(resin)
Toronto resin 100 None
6 Delayed
toronto 
(resin)
Implant-supported 
fixed prosthesis
100 None
7 Delayed
toronto 
(resin)
Removable 
prosthesis
100 None
8 Delayed
toronto 
(resin)
Implant-supported 
fixed prosthesis 
and natural teeth
100 None
9 Delayed
toronto 
(resin)
Natural teeth-
supported fixed 
prosthesis
100 None
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 FIGURE 1 The initial intraoral image of an ectodermal dysplasia patient. 
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 FIGURE 2 The initial panoramic x-ray image of the patient 
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 FIGURE 3 The post-prosthetic intraoral image of the patient. 
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 FIGURE 4 The panoramic x-ray image of the same ectodermal dysplasia patient 18 months after implant 
insertion surgery. Note: The conventional implants in the lower jaw of this patient were inserted using the 
technique of bypass of the inferior alveolar nerve. In this case, the position of the nerve was superficial, 
situated rather buccally in the mandibular bone and insertion of the implant was possible without damaging 
the nerve. 
94x45mm (300 x 300 DPI) 
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 FIGURE 5:- The intra-oral view of the patient 18 months after implant surgery. Front view. 
383x255mm (300 x 300 DPI) 
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 FIGURE 6: The intra-oral view of the patient 18 months after implant surgery. Occlusal view. 
272x183mm (300 x 300 DPI) 
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 FIGURE 7: The panoramic x-ray image of the patient 26 months after implant surgery. 
119x56mm (300 x 300 DPI) 
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STROBE (Strengthening The Reporting of OBservational Studies in Epidemiology) Checklist  
 
A checklist of items that should be included in reports of observational studies. You must report the page number in your manuscript 
where you consider each of the items listed in this checklist. If you have not included this information, either revise your manuscript 
accordingly before submitting or note N/A. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published 
examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web 
sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology 
at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org. 
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Recommendation 
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Page No. 
Title and Abstract  1 (a) Indicate the study’s design with a commonly used term in the title or the 
abstract  
 
(b) Provide in the abstract an informative and balanced summary of what was 
done and what was found   
 
Introduction  
Background/Rationale 2 Explain the scientific background and rationale for the investigation being 
reported   
 
Objectives 3 State specific objectives, including any prespecified hypotheses   
Methods  
Study Design 4 Present key elements of study design early in the paper   
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection  
 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up  
Case-control study—Give the eligibility criteria, and the sources and methods of 
case ascertainment and control selection. Give the rationale for the choice of 
cases and controls  
Cross-sectional study—Give the eligibility criteria, and the sources and methods of 
selection of participants 
 
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed  
Case-control study—For matched studies, give matching criteria and the number 
of controls per case   
 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and 
effect modifiers. Give diagnostic criteria, if applicable  
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Data Sources/ 
Measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if 
there is more than one group   
 
Bias 9 Describe any efforts to address potential sources of bias    
Study Size 10 Explain how the study size was arrived at    
Quantitative Variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why  
 
Statistical Methods 12 (a) Describe all statistical methods, including those used to control for 
confounding   
 
(b) Describe any methods used to examine subgroups and interactions    
(c) Explain how missing data were addressed   
(d) Cohort study—If applicable, explain how loss to follow-up was addressed  
Case-control study—If applicable, explain how matching of cases and controls was 
addressed   
Cross-sectional study—If applicable, describe analytical methods taking account of 
sampling strategy   
 
(e) Describe any sensitivity analyses   
Results     
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed 
 
  (b) Give reasons for non-participation at each stage    
  (c) Consider use of a flow diagram    
Descriptive Data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders    
 
  (b) Indicate number of participants with missing data for each variable of interest    
  (c) Cohort study—Summarise follow-up time (eg, average and total amount)     
Outcome Data 15* Cohort study—Report numbers of outcome events or summary measures over 
time   
 
  Case-control study—Report numbers in each exposure category, or summary 
measures of exposure   
 
  Cross-sectional study—Report numbers of outcome events or summary measures    
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Main Results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates 
and their precision (eg, 95% confidence interval). Make clear which confounders 
were adjusted for and why they were included   
 
  (b) Report category boundaries when continuous variables were categorized    
  (c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period   
 
Other Analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses   
 
Discussion    
Key Results 18 Summarise key results with reference to study objectives    
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias   
 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence   
 
Generalisability 21 Discuss the generalisability (external validity) of the study results    
Other Information    
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based   
 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in 
cohort and cross-sectional studies. 
 
Once you have completed this checklist, please save a copy and upload it as part of your submission. DO NOT include this 
checklist as part of the main manuscript document. It must be uploaded as a separate file. 
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